Artavazd Arumov is a cancer biologist and venture capitalist. He has experience managing clinical trials and currently works at Qiming Venture Partners USA.
At firms with a similar stage, sector and check size.






One email when Artavazd's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckArtavazd Arumov is a cancer biologist and venture capitalist. He has experience managing clinical trials and currently works at Qiming Venture Partners USA.
Artavazd Arumov invests through Qiming Venture Partners USA, which writes checks of $1M to $10M at pre-seed, seed, series a, series b.
A warm intro from a founder Qiming Venture Partners USA backed works best.
Adjunct Professor of Biology at St. Francis College; Research Associate at Icahn School of Medicine at Mount Sinai; Clinical Research Associate at Memorial Sloan Kettering Cancer Center; Business Development Lead at Redesign Science; Associate at University of Miami Miller School of Medicine; Entrepreneur in Residence at U Innovation's Coulter Center for Translational Research.
Last updated 2026-10-15. Is this you? Ask for a correction.